We have also evaluated the impact of a potent small molecular inhibitor of hepatocellular carcinoma, 1,2,3,4,6-penta-O-galloyl-β-d-glucopyranoside, which has previously been shown to act in part by upregulating the expression of GNMT [20]. The gene discussed is GNMT; the disease is hepatocellular carcinoma.